Form 4: Cardio Diagnostics Director James Intrater Acquires Additional Stock Options
Insider Transaction Report
Cardio Diagnostics Holdings, Inc. Director James Intrater acquired 1,736 stock options at an exercise price of $3.60, increasing his total beneficial ownership of derivative securities to 3,394.
Summary
- James Intrater, a Director of Cardio Diagnostics Holdings, Inc. (CDIO), acquired 1,736 stock options.
- The options have an exercise price of $3.60 per share.
- These newly acquired options become exercisable on June 30, 2025, and are set to expire on June 30, 2035.
- Following this transaction, Mr. Intrater's total beneficial ownership of derivative securities (stock options) in the company increased to 3,394.
Sentiment
Score: 7
Explanation: The acquisition of stock options by a director is generally viewed as a positive signal of confidence in the company's future prospects, although the filing itself provides limited financial or operational details.
Positives
- Director James Intrater increased his beneficial ownership of company stock options, potentially signaling confidence in future company performance and alignment with shareholder interests.
Future Outlook
The document does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.
Industry Context
This filing is a routine disclosure of an insider transaction and does not provide information related to broader industry trends or competitive landscape.
Related Party Transactions
- Acquisition of 1,736 stock options by James Intrater, a Director of Cardio Diagnostics Holdings, Inc., from the company. This is a direct transaction between an insider and the issuer.
Stakeholder Impact
- Shareholders: May interpret the director's acquisition of options as a positive signal of confidence in the company's future, potentially influencing investor sentiment.
- Employees, Customers, Suppliers, Creditors: No direct or immediate impact from this specific insider transaction filing.
Key Dates
| Date | Description |
|---|---|
| 06/30/2025 | Date of the stock option transaction and when the options become exercisable. |
| 07/02/2025 | Date the Form 4 was signed and filed with the SEC. |
| 06/30/2035 | Expiration date of the acquired stock options. |
Keywords
Cardio Diagnostics Holdings, CDIO, SEC Form 4, Insider Transaction, Stock Options, Beneficial Ownership, Director, James Intrater
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.